Fractyl Health, Inc. Fair Value Adjustment of Warrants
Fractyl Health, Inc. (GUTS) reported Fair Value Adjustment of Warrants of $5.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-10
- Fractyl Health, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $5.48M, a 1475.86% increase year-over-year.
- Fractyl Health, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$30.05M.
- Fractyl Health, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was $20.18M.
- Fractyl Health, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $21.20M.
- Fractyl Health, Inc. fair value adjustment of warrants for fiscal 2025 was $40.90M.
- Fractyl Health, Inc. fair value adjustment of warrants for fiscal 2024 was -$17.91M, a 363.59% decline from fiscal 2023.
- Fractyl Health, Inc. fair value adjustment of warrants for fiscal 2023 was $6.79M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.48M 10-Q · filed 2026-08-10 | -$24.57M 10-Q · filed 2026-08-10 | -$4.39M derived: sum of 3 quarters · filed 2026-08-10 | $16.81M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$30.05M 10-Q · filed 2026-05-12 | -$9.88M derived: sum of 2 quarters · filed 2026-05-12 | $11.32M derived: sum of 3 quarters · filed 2026-05-12 | $11.67M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $20.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $41.38M derived: sum of 2 quarters · filed 2026-03-24 | $41.73M derived: sum of 3 quarters · filed 2026-08-10 | $40.90M 10-K · filed 2026-03-24 |
| 2025-09-30 | $21.20M 10-Q · filed 2025-11-12 | $21.55M derived: sum of 2 quarters · filed 2026-08-10 | $20.72M 10-Q · filed 2025-11-12 | $20.26M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $348.00K 10-Q · filed 2026-08-10 | -$477.00K 10-Q · filed 2026-08-10 | -$943.00K derived: sum of 3 quarters · filed 2026-08-10 | -$3.24M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$825.00K 10-Q · filed 2026-05-12 | -$1.29M derived: sum of 2 quarters · filed 2026-05-12 | -$3.58M derived: sum of 3 quarters · filed 2026-05-12 | -$8.29M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$2.76M derived: sum of 2 quarters · filed 2026-03-24 | -$7.46M derived: sum of 3 quarters · filed 2026-03-24 | -$17.91M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$2.29M 10-Q · filed 2025-11-12 | -$7.00M derived: sum of 2 quarters · filed 2025-11-12 | -$17.44M 10-Q · filed 2025-11-12 | -$11.81M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$4.70M 10-Q · filed 2025-08-12 | -$15.15M 10-Q · filed 2025-08-12 | -$9.52M derived: sum of 3 quarters · filed 2025-08-12 | -$8.49M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$10.45M 10-Q · filed 2025-05-13 | -$4.81M derived: sum of 2 quarters · filed 2025-05-13 | -$3.79M derived: sum of 3 quarters · filed 2025-05-13 | -$3.66M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $6.66M derived: sum of 2 quarters · filed 2025-03-03 | $6.79M derived: sum of 3 quarters · filed 2025-03-03 | $6.79M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.03M 10-Q · filed 2024-11-12 | $1.16M derived: sum of 2 quarters · filed 2024-11-12 | $1.16M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $129.00K 10-Q · filed 2024-08-14 | $134.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $5.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |